Uploaded August 2026 | Updated September 2026, 2 weeks ago
The FDA has approved the new drug Rasonque for metastatic pancreatic cancer patients as a chemotherapy alternative.
The FDA has approved the new drug Rasonque for metastatic pancreatic cancer patients as a chemotherapy alternative.










